In Utero Enzyme-Replacement Therapy for Infantile-Onset Pompe’s Disease

Amazing therapeutic success led by UCSF Pediatrics joined by Duke UniversityOttawa University, and Washington University via in-utero enzyme-replacement therapy for infantile-onset Pompe’s disease: Patients with early-onset lysosomal storage diseases are ideal candidates for prenatal therapy because organ damage starts in utero. After receiving in-utero ERT and standard postnatal therapy, the current patient had normal cardiac and age-appropriate motor function postnatally, was meeting developmental milestones, had normal biomarker levels, and was feeding and growing well at 13 months of age.

See the full article here

Design, Synthesis, and Characterization of Stapled Oligosaccharides

From peptides to sugars: Design, Synthesis, and Characterization of Stapled Oligosaccharides. Oligosaccharide stapling increases enzymatic stability and cell penetration, opening new opportunities for using glycans in medicinal chemistry. – Max Planck Institute Manuel Garcia RicardoEmelie Ellen Reuber, Ling Yao, José Angel Danglad-FloresMartina DelbiancoPeter Seeberger
Wonderful chemistry and insightful new possibilities.

See the full article here